Controversies in medicine: redefining the diagnosis of type 1 diabetes

• 1 Women's and Children's Hospital, Adelaide, SA
• 2 University of Adelaide, Adelaide, SA
• 3 Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC

---

• 1. Haynes A, Bulsara MK, Bower C, et al. Regular peaks and troughs in the Australian incidence of childhood type 1 diabetes mellitus (2000–2011). Diabetologia 2015; 58: 2513–2516.
• 2. Phelan H, Clapin H, Bruns L, et al. The Australasian Diabetes Data Network: first national audit of children and adolescents with type 1 diabetes. Med J Aust 2017; 206: 121–125. https://www.mja.com.au/journal/2017/206/3/australasian-diabetes-data-network-first-national-audit-children-and-adolescents
• 3. Ziegler AG, Rewers M, Simell O, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 2013; 309: 2473–2479.
• 4. Raab J, Haupt F, Scholz M, et al. Capillary blood islet autoantibody screening for identifying pre‐type 1 diabetes in the general population: design and initial results of the Fr1da study. BMJ Open 2016; 6: e11144.
• 5. Insel RA, Dunne JL, Atkinson MA, et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society and the American Diabetes Association. Diabetes Care 2015; 38: 1964–1974.
• 6. Colman PG, McNair P, Margetts H, et al. The Melbourne Pre‐Diabetes Study: prediction of type 1 diabetes mellitus using antibody and metabolic testing. Med J Aust 1998; 169: 81–84.
• 7. Bonifacio E, Mathieu C, Nepom GT, et al. Rebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entity. Diabetologia 2017; 60: 35–38.
• 8. Department of Health. Australian National Diabetes Strategy 2016–2020. Canberra: Commonwealth of Australia, 2015. http://www.health.gov.au/internet/main/publishing.nsf/Content/nds-2016-2020 (viewed Jan 2019).
• 9. King BR, Howard NJ, Verge CF, et al. A diabetes awareness campaign prevents diabetic ketoacidosis in children at their initial presentation with type 1 diabetes. Pediatr Diabetes 2012; 13: 647–651.
• 10. Duca LM, Wang B, Rewers M, Rewers A. Diabetic ketoacidosis at diagnosis of type 1 diabetes predicts poor long‐term glycemic control. Diabetes Care 2017; 4: 1249–1255.
• 11. Winkler C, Schober E, Ziegler AG, Holl RW. Markedly reduced rate of diabetic ketoacidosis at onset of type 1 diabetes in relatives screened for islet autoantibodies. Pediatr Diabetes 2012; 13: 308–313.
• 12. Steck AK, Larsson HE, Liu X, et al. Residual beta‐cell function in diabetes children followed and diagnosed in the TEDDY study compared with community controls. Pediatr Diabetes 2017; 18: 794–802.
• 13. Gesualdo PD, Bautista KA, Waugh KC, et al. Feasibility of screening for T1D and celiac disease in a pediatric clinic setting. Pediatr Diabetes 2016; 17: 441–448.
• 14. Smith LB, Liu X, Johnson SB, et al. Family adjustment to diabetes diagnosis in children: can participation in a study on type 1 diabetes genetic risk be helpful? Pediatr Diabetes 2018; 19: 1025–1033.
• 15. Herold KC, Bundy BN, Long A, et al. An anti‐CD3 antibody, teplizumab, in relatives with type 1 diabetes. N Engl J Med 2019. https://doi.org/10.1056/nejmoa1902226. [Epub ahead of print]
• 16. Bingley PJ, Bonifacio E, Williams AJ, et al. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 1997; 46: 1701–1710.